0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

ARDS - Epidemiology Forecast to 2032 - Product Thumbnail Image

ARDS - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Bronchial Spasm - Epidemiology Forecast - 2032 - Product Thumbnail Image

Bronchial Spasm - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Pharyngitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pharyngitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Emphysema - Epidemiology Forecast - 2032 - Product Thumbnail Image

Emphysema - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Pertussis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pertussis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Pneumoconiosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Pneumoconiosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
Pulmonary Fibrosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pulmonary Fibrosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
EUR$3,950USDGBP
From
EUR$3,950USDGBP
Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Ofev (Nintedanib) - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
EUR$2,750USDGBP
From
EUR$2,750USDGBP
From
EUR$4,000USDGBP
From
EUR$4,750USDGBP
From
EUR$3,750USDGBP
From
EUR$3,750USDGBP
From
EUR$4,950USDGBP
From
EUR$4,950USDGBP
From
EUR$4,950USDGBP
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more

This website uses cookies to ensure you get the best experience. Learn more